Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.746 SEK | +5.75% | -1.12% | +26.97% |
05-23 | Cantargia Presents New Positive Clinical Data on Nadunolimab Counteracting Chemotherapy Induced Neuropathy | CI |
05-21 | Transcript : Cantargia AB, Q1 2024 Earnings Call, May 21, 2024 |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+26.97% | 82.71M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- CANTA Stock
- News Cantargia AB
- Cantargia AB Elect Magnus Nilsson and Damian Marron as New Board Members